Pro Medicus (OTCMKTS:PMCUF) Shares Gap Up – What’s Next?

Pro Medicus Limited (OTCMKTS:PMCUFGet Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $133.60, but opened at $143.4960. Pro Medicus shares last traded at $143.4960, with a volume of 328 shares traded.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group lowered shares of Pro Medicus from a “buy” rating to a “hold” rating in a research note on Wednesday, July 8th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $155.00.

Get Our Latest Research Report on PMCUF

Pro Medicus Price Performance

The business has a 50 day moving average price of $126.74 and a 200-day moving average price of $106.14.

Pro Medicus Company Profile

(Get Free Report)

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.

See Also

Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.